Getting to the Heart of Type 2 Diabetes Mellitus
Description Heading link
Background:
In August 2019, the State of Illinois passed Public Act 101-0278, requiring the establishment of an evidence-based, non-commercial education program for Medicaid prescribers consisting of a web-based curriculum and academic educator outreach. As a result of this legislation, the Illinois Department of Healthcare and Family Services is partnering with the University of Illinois at Chicago College of Pharmacy to provide drug information and academic detailing services through Illinois ADVANCE.
What is academic detailing:
Academic detailing is a one-on-one prescriber outreach program. It provides accurate, non-commercial, and up-to-date pharmacotherapy information. It is a unique interactive program tailored for each prescriber through customized and focused discussions. The educational materials provided during these visits are developed after a careful review of current clinical evidence.
How to participate and obtain CE:
Sign up for a 0.5 hour academic detailing session on one or more of the available CE topics at https://illinoisadvance.uic.edu/schedule-a-visit/.
You will meet with a clinical pharmacist for a brief academic detailing visit. Upon completion of the session, you will complete an activity evaluation survey.
For more information about the CEs or the CE topics, contact illinoisadvance@uic.edu.
Disclosures Heading link
Provider Academic Detailer Speaker:
Please visit https://illinoisadvance.uic.edu/meet-the-team/ for a list of potential speakers.
Disclosure (s):
The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.
- Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Dynavax Technologies Corp, Esperion Therapeutics Inc, Gilead Sciences Inc, Glasko Smith Kline, Haleon, EOM Pharmaceuticals, Lisata Therapeutics Inc, Novavax Inc, Pfizer Inc, Protalix Biotherapeutics Inc, and PuImatrix Inc.
- Speaker, Dr. Thomas Dorn has stock ownership with companies Inovio Pharmaceuticals, Eli Lily, and Lexicon Pharmaceuticals.
- Speaker, Dr. Sajitha Purathur has stock ownership with Pfizer.
- Speaker, Dr. Chirag Rathod has stock ownership with MindMed.
- Speaker, Dr. Stewart Chung has stock ownership with Silo Pharmaceutical.
All relevant financial relationships listed for the above speakers have been mitigated.
Learning Objectives Heading link
Type of Activity: Knowledge-based
Learning Objectives:
- Describe current treatment recommendations for type 2 diabetes in patients with cardiovascular or renal risk factors
- Discuss the glucose lowering efficacy of various medications
Activity Information Heading link
| Target Audience: | Physicians, Physician Assistant, Nurse Practitioners | Fee: | Free |
| Release Date: | March 15, 2024 | Expiration Date: | March 10, 2026 |
| Estimated time to complete: | 0.5 hour | CE: | 0.5 contact hour CME (0.5 AMA PRA Category 1 Credit) |
Go to activity
Activity Information Heading link
How to Earn Credit:
Participants must complete the activity as described below in the Continuing Medical Education Statement by completing the activity evaluation. A certificate of completion will be issued after all requirements as described are completed.
Hardware/Software and Internet Requirements can be found at https://medicinece.uic.edu/.
Provider Contact Information:
For information about IL Advance, your academic detailing appointment, or more information about the available CE topics, please email illinoisadvance@uic.edu.
For general information about the CE activity evaluation or CE credit information, please email pharmce@uic.edu.
Copyright © 2024– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy